173 related articles for article (PubMed ID: 25599961)
21. Serum levels of pepsinogen I and gastrin in gastric carcinoma: the influence of Helicobacter pylori infection and tumor characteristics.
Lin JT; Wang JT; Wu MS; Huang SC; Wang TH
Hepatogastroenterology; 1993 Dec; 40(6):600-3. PubMed ID: 8119648
[TBL] [Abstract][Full Text] [Related]
22. High Serum Pepsinogen I and beta Helicobacter pylori Infection Are Risk Factors for Aspirin-Induced Gastroduodenal Injury.
Shan J; Lei H; Shi W; Sun X; Tang Y; Ren C
Dig Dis; 2018; 36(1):66-71. PubMed ID: 28595197
[TBL] [Abstract][Full Text] [Related]
23. Helicobacter pylori and Schistosoma japonicum co-infection in a Chinese population: helminth infection alters humoral responses to H. pylori and serum pepsinogen I/II ratio.
Du Y; Agnew A; Ye XP; Robinson PA; Forman D; Crabtree JE
Microbes Infect; 2006 Jan; 8(1):52-60. PubMed ID: 16260169
[TBL] [Abstract][Full Text] [Related]
24. [Relationship between pepsinogen I/II ratio and age or upper gastrointestinal diseases in Helicobacter pylori-positive and -negative subjects].
Paik CN; Chung IS; Nam KW; Kwon JH; Chang JH; Suh JP; Park JM; Cho YK; Lee IS; Kim SW; Choi MG
Korean J Gastroenterol; 2007 Aug; 50(2):84-91. PubMed ID: 17928751
[TBL] [Abstract][Full Text] [Related]
25. Oxyntic gastric atrophy in Helicobacter pylori gastritis is distinct from autoimmune gastritis.
Venerito M; Varbanova M; Röhl FW; Reinhold D; Frauenschläger K; Jechorek D; Weigt J; Link A; Malfertheiner P
J Clin Pathol; 2016 Aug; 69(8):677-85. PubMed ID: 26729016
[TBL] [Abstract][Full Text] [Related]
26. Relationship among serum pepsinogens, serum gastrin, gastric mucosal histology and H. pylori virulence factors in a paediatric population.
Lopes AI; Palha A; Lopes T; Monteiro L; Oleastro M; Fernandes A
Scand J Gastroenterol; 2006 May; 41(5):524-31. PubMed ID: 16638693
[TBL] [Abstract][Full Text] [Related]
27. Non-endoscopic diagnosis of multifocal atrophic gastritis; efficacy of serum gastrin-17, pepsinogens and Helicobacter pylori antibodies.
Hartleb M; Wandzel P; Waluga M; Matyszczyk B; Bołdys H; Romañczyk T
Acta Gastroenterol Belg; 2004; 67(4):320-6. PubMed ID: 15727075
[TBL] [Abstract][Full Text] [Related]
28. A significant increase in the pepsinogen I/II ratio is a reliable biomarker for successful Helicobacter pylori eradication.
Osumi H; Fujisaki J; Suganuma T; Horiuchi Y; Omae M; Yoshio T; Ishiyama A; Tsuchida T; Miki K
PLoS One; 2017; 12(8):e0183980. PubMed ID: 28854276
[TBL] [Abstract][Full Text] [Related]
29. The new modified ABCD method for gastric neoplasm screening.
Park CH; Kim EH; Jung DH; Chung H; Park JC; Shin SK; Lee SK; Lee YC
Gastric Cancer; 2016 Jan; 19(1):128-35. PubMed ID: 25663259
[TBL] [Abstract][Full Text] [Related]
30. Follow-up study on a high risk population of gastric cancer in north China by serum pepsinogen assay.
Sun LP; Gong YH; Wang L; Gong W; Yuan Y
J Dig Dis; 2008 Feb; 9(1):20-6. PubMed ID: 18251790
[TBL] [Abstract][Full Text] [Related]
31. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
[TBL] [Abstract][Full Text] [Related]
32. [Influence of impaired renal function and Helicobacter pylori infection on serum pepsinogen concentrations].
Murakawa M
Nihon Jinzo Gakkai Shi; 1999 Jun; 41(4):399-405. PubMed ID: 10441989
[TBL] [Abstract][Full Text] [Related]
33. Examination of serum pepsinogen in functional dyspepsia.
Tahara T; Shibata T; Okubo M; Yamashita H; Yoshioka D; Yonemura J; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Yamada H; Nakamura M; Arisawa T; Hirata I
Hepatogastroenterology; 2012; 59(120):2516-22. PubMed ID: 23178618
[TBL] [Abstract][Full Text] [Related]
34. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
Bölükbaş C; Bölükbaş FF; Ovünç O; Kiliç G; Dalay R; Güven H; Uras F; Yardimci TK; Sökmen MH; Agan AF; Pişkinpaşa N
Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
[TBL] [Abstract][Full Text] [Related]
35. [Clinical utility of serum pepsinogen levels as a screening test of atrophic gastritis].
Chae H; Lee JH; Lim J; Kim M; Kim Y; Han K; Kang CS; Shim SI; Kim JI; Park SH
Korean J Lab Med; 2008 Jun; 28(3):201-6. PubMed ID: 18594172
[TBL] [Abstract][Full Text] [Related]
36. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.
Konturek PC; Konturek SJ; Bielanski W; Karczewska E; Pierzchalski P; Duda A; Starzynska T; Marlicz K; Popiela T; Hartwich A; Hahn EG
J Physiol Pharmacol; 1999 Dec; 50(5):857-73. PubMed ID: 10695565
[TBL] [Abstract][Full Text] [Related]
37. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
[TBL] [Abstract][Full Text] [Related]
38. An association between Helicobacter pylori infection and serum vitamin B12 levels in healthy adults.
Shuval-Sudai O; Granot E
J Clin Gastroenterol; 2003 Feb; 36(2):130-3. PubMed ID: 12544195
[TBL] [Abstract][Full Text] [Related]
39. Relationship between Helicobacter pylori infection, atrophic gastritis and gastric carcinoma in a Japanese population.
Asaka M; Kato M; Kudo M; Katagiri M; Nishikawa K; Yoshida J; Takeda H; Miki K
Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S7-10. PubMed ID: 8574741
[TBL] [Abstract][Full Text] [Related]
40. Implications of oral Helicobacter pylori for the outcome of its gastric eradication therapy.
Czesnikiewicz-Guzik M; Loster B; Bielanski W; Guzik TJ; Konturek PC; Zapala J; Konturek SJ
J Clin Gastroenterol; 2007 Feb; 41(2):145-51. PubMed ID: 17245212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
